title: Complement activation and rituximab distribution in CNS NHL--letter.
authors.affiliation: Department of Oncology, University Hospital Zurich, Zurich, Switzerland. Division of Medical Oncology, Kantonsspital Luzern, Luzern, Switzerland. silvia.hofer@luks.ch.
authors.forename: Silvia
authors.initials: S
authors.lastname: Hofer
authors.affiliation: Clinical Research Unit, Department of Obstetrics and Gynecology, Technische Universität Munich, Munich, Germany.
authors.forename: Karin
authors.initials: K
authors.lastname: Mengele
authors.affiliation: Clinical Research Unit, Department of Obstetrics and Gynecology, Technische Universität Munich, Munich, Germany.
authors.forename: Manfred
authors.initials: M
authors.lastname: Schmitt
authors.affiliation: Department of Oncology, University Hospital Zurich, Zurich, Switzerland.
authors.forename: Bernhard
authors.initials: B
authors.lastname: Pestalozzi
authors.affiliation: Division of Medical Oncology, Kantonsspital Luzern, Luzern, Switzerland.
authors.forename: Stefan
authors.initials: S
authors.lastname: Aebi
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000493:pharmacokinetics*; D000970:Antineoplastic Agents / Q000493:pharmacokinetics*; D016543:Central Nervous System Neoplasms / Q000134:cerebrospinal fluid*; D003167:Complement Activation; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000134:cerebrospinal fluid*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000134:cerebrospinal fluid*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents